Monday, November 30, 2015
Text Size

Site Search powered by Ajax



Employment Inquiries

For inquiries about employment at NanoVir, LLC please send Curriculum Vitae (CV) to This email address is being protected from spambots. You need JavaScript enabled to view it.">This email address is being protected from spambots. You need JavaScript enabled to view it. .

University of Missouri-St. Louis Resources

Chemistry Facilities: NanoVir’s chemistry laboratory is located, via a collaborative agreement, in the Department of Chemistry & Biochemistry at University of Missouri-St. Louis. The chemistry laboratory is well-equipped for chemical synthesis. It consists of 760+ sq. ft of lab space and four hoods, an HPLC/mass spectrometer, automated peptide synthesizers and several sizes of preparative HPLC. The chemistry lab also has access to state-of-the-art equipment including major instrumentation facilities for NMR, X-ray crystallography and mass spectrometry.

Kalamazoo Resources

Biology Facilities: The biological laboratory of NanoVir LLC is located at the Southwest Michigan Innovation Center in Kalamazoo, Michigan, a 58,000 square foot multi-tenant facility. NanoVir, LLC occupies 1200 square feet of laboratory space with with state-of-the art equipment, biological safety level 2 containment, and additional shared equipment available.

Funding History

NanoVir's promising research into DNA-targeted treatments for HPV has been consistently recognized by the scientific funding community. ( To see issued  patent, click here.)

2008 -2010
Phase 2 STTR Grant - $3,000,000
This grant will enable development of broad spectrum anti HPV compounds

RO1 Grant - $1,830,000
This grant allows basic studies of antiviral mechanisms of actions

Phase 2 STTR Grant - $2,980,000
This grant will allow development of an antiviral treatment for HPV16

Phase 1 STTR - $980,000
Allows identification of compound targeting HPV 18

Phase 1 STTR - $780,000
Enables initial targeting of HPV 16

Bioscience Research & Commercialization Center - $218,000
HPV research

Page 1 of 2